In addition, several studies suggest that due to the overlapping levels of Aβ1–42, T-tau, and p-tau181 in CSF, it cannot effectively distinguish AD patients from other types of dementia patients [64]. The gene discussed is MAPT; the disease is Alzheimer disease.